October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Peter Pisters: Honoring the late Michael Frumovitz at MD Anderson Cancer Center’s Julie and Ben Rogers Award for Excellence ceremony
Oct 4, 2024, 15:17

Peter Pisters: Honoring the late Michael Frumovitz at MD Anderson Cancer Center’s Julie and Ben Rogers Award for Excellence ceremony

Peter Pisters shared a post on LinkedIn:

“At MD Anderson Cancer Center‘s Julie and Ben Rogers Award for Excellence ceremony, we honored the late Dr. Michael Frumovitz. His extraordinary compassion, strength and impact as our Chief Patient Experience Officer will be felt for years to come.

I was grateful for the opportunity to recognize Michael, his family and our award finalists in today’s heartfelt ceremony.”

Peter Pisters: Honoring the late Michael Frumovitz at MD Anderson Cancer Center's Julie and Ben Rogers Award for Excellence ceremony

Who was Michael Frumovitz?

Michael Frumovitz, M.D., was a gynecologic oncologist and professor at the University of Texas MD Anderson Cancer Center. He passed away on July 25, 2024, after more than 20 years of service at MD Anderson.

Dr. Frumovitz was known for his expertise in rare gynecologic tumors and played a crucial role in founding the Rare Tumor Program at the institution.He was highly regarded for his compassionate patient care, mentorship, and contributions to medical education. As Chief Patient Experience Officer, he focused on enhancing the human experience for patients and their families.

Dr. Frumovitz authored nearly 190 peer-reviewed articles and held significant leadership roles, including directing the MD Anderson Gynecologic Oncology Fellowship.In honor of his legacy, an endowment has been established to support clinical research, education, and training in gynecologic oncology, particularly focusing on rare tumors. His work has left a lasting impact on the field and the many patients he served.

Michael Frumovitz

 

Source: Peter Pisters/LinkedIn

Peter Pisters leads The University of Texas MD Anderson Cancer Center, driving research in cardiology, transplantation, neurosciences, oncology, surgical innovation, infectious diseases, genomic medicine, and rehabilitation medicine. He contributes to academic journals like the Journal of Clinical Oncology and Surgery, and reviews for various publications. His research, concentrated on sarcomas, GI cancers, and other malignancies.